课题基金 / 基金详情

BRCA1 and the Inactive X Chromosome

BRCA1 and the Inactive X Chromosome
BRCA1 和失活 X 染色体
批准号:
7192487
负责人:
DAVID Morse LIVINGSTON
金额:
$32.89万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-05-05 至 2009-02-28

项目摘要

项目成果

DAVID Morse LIVINGSTON的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): BRCA1 is a tumor suppressor gene, germ line mutation of which can result in inherited breast and ovarian cancer. How BRCA1 delivers its disease-preventing effects and why they are clinically apparent only in selected estrogen target cells of females is a mystery. In this regard, the protein is expressed in a wide spectrum of proliferarting male and female cells. Recently, we have observed that a fraction of the BRCA1 in female somatic cells is concentrated on the inactive X chromosomes (Xi). Its presence there is necessary for the colocalization of the noncoding RNA, Xist and the specialized histone, Macrohistone H2A 1.2. Both of these elements play a key role in the X inactivation process during embryogenesis. Furthermore, BRCA1 interacts with Xist, although whether or not this is a direct interaction remains unclear. Although neither X chromosome in BRCA1- deficient tumor cells carried associated Xist or MH2A, the abundance of these elements in such cells was the same as in their BRCA1- producing derivatives or counterparts. Hence, where studied, BRCA1 appears to promote the localization of Xist and MH2A on Xi rather than directing their synthesis or controlling their stability. Finally, multiple human and murine BRCA1 -/- tumors lack a readily detectable Xi structure despite the presence of 2 X chromosomes. This proposal is aimed at understanding the biochemical bases for these phenomena. Since both BRCA1 tumor suppression and the BRCAI->Xist/Xi effects are female-specific processes, the proposal is also aimed at learning whether these phenomena are linked.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Deciphering the mechanism underlying BRCA1 breast cancer development
  • 批准号:
    10218120
  • 项目类别:
  • 资助金额:
    $105.34万
  • 财政年份:
    2019
  • 负责人:
    DAVID Morse LIVINGSTON
  • 依托单位:
Deciphering the mechanism underlying BRCA1 breast cancer development
  • 批准号:
    9814452
  • 项目类别:
  • 资助金额:
    $84.51万
  • 财政年份:
    2019
  • 负责人:
    DAVID Morse LIVINGSTON
  • 依托单位:
BRCA1 Function in Post-Damage Nuclear Foci
  • 批准号:
    9454879
  • 项目类别:
  • 资助金额:
    $3.38万
  • 财政年份:
    2017
  • 负责人:
    DAVID Morse LIVINGSTON
  • 依托单位:
Viral Oncoprotein Inhibition of Quiescence
  • 批准号:
    8233033
  • 项目类别:
  • 资助金额:
    $44.63万
  • 财政年份:
    2011
  • 负责人:
    DAVID Morse LIVINGSTON
  • 依托单位:
海外基金